26/03/2026
SPHFU at the XIX Congress "Development and Registration of Medicines"The event was held in Moscow at the Sechenov University Congress Center.
The "Development and Registration of Drugs" congress has been held annually since 2012, and during this time it has become a highly anticipated industry event in the pharmaceutical world. Its topics traditionally cover all key stages of the drug life cycle, from development to post-registration processes.The event was held in Moscow at the Sechenov University Congress Center.
The "Development and Registration of Drugs" congress has been held annually since 2012, and has become a highly anticipated industry event in the pharmaceutical world. Its topics traditionally cover all key stages of the life cycle of drugs - from development to post-registration processes. This year, the geography of participants has significantly expanded: representatives of not only Russian organizations and universities (Saint Petersburg State Chemical-Pharmaceutical University (SPhPU), I.M. Sechenov First Moscow State Medical University, Perm State Pharmaceutical Academy, Voronezh State University, Ryazan State Medical University named after Academician I.P. Pavlov, Scientific Center for Expertise of Medicinal Products, K.I. Skryabin Moscow State Academy of Veterinary Medicine and Biotechnology, Limited Liability Company "Center for Pharmaceutical Analytics"), but also participants from the Republic of Belarus (Belarusian State Medical University, Minsk) and the Republic of Kazakhstan (South Kazakhstan Medical Academy, Shymkent) addressed the audience and the authoritative jury. Within the framework of the congress, industry representatives studied issues of pharmaceutical development and registration of drugs, regulatory issues of current legislation, modern trends in preclinical, clinical and registration laboratory studies, as well as other topics.
Representatives of SPHFU actively participated in the congress. Denis Nikolaevich Maimistov, Head of the SPHFU Additive Technologies Laboratory, delivered a presentation on the topic "Young Pharmacy — Potential of the Future: New Conference Architecture and Developing a Culture of Scientific Publication."
"Young Pharmacy — Potential of the Future" is an all-Russian scientific conference with international participation, held annually at SPHFU. The conference covers various topics, including chemical synthesis technology, pharmaceuticals, cosmetics, functional foods, and dietary supplements, current aspects of biotechnology, pharmacology, standardization, and pharmaceutical organization. The conference also featured sections on "Secondary Vocational Education: Research in Pharmaceutics" and "My Step into Science and Technology: From First Trials to Big Challenges."
SPHFU staff also moderated the sections "What Components Make Up a High-Quality Preclinical Study?" (Dmitry Yuryevich Ivkin) and "Quality of Medicines at Life Cycle Stages: A Path Without End or No Limit to Perfection" (Inna Ivanovna Terninko).
The 2nd Youth League of Medicine Development and Registration was held as part of the 19th Congress "Drug Development and Registration" (Drug Development and Registration), which has already become a traditional forum for young scientists during the congress.
Anna Yuryevna Grishina, a fourth-year postgraduate student majoring in Pharmacology and Clinical Pharmacology, won the 2nd Youth League of Medicine Development and Registration. Anna presented a paper on the molecular mechanisms and pathogenetic aspects of the nephroprotective action of malonic acid derivatives. Anna's scientific advisor was Dmitry Yuryevich Ivkin, PhD, in Biology. Anna received a commemorative cup, souvenir prizes from the journal "Drug Development and Registration" (Drug Development and Registration), and a certificate for free publication in the journal.
The CFA team also awarded a special prize in the form of a certificate for an internship at the company to Ulyana Andreevna Efremova.
Daria ZELIKOVA